{"date":"2025-04-11","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6879-2025-04-11-1814-6rqyk5","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"18:14:39","subject":"公告本公司取得有價證券","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-04-11 18:14，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-04-11-1804-fhdtqg","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"18:04:51","subject":"公告本公司董事會決議通過變更營業地址","clause":"第44款","fact_date":"2025-04-11","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-04-11 18:04，「公告本公司董事會決議通過變更營業地址」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-04-11-1804-1s04pqb","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"18:04:29","subject":"公告本公司董事會決議召開114年股東常會(新增議案)","clause":"第32款","fact_date":"2025-04-11","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-04-11 18:04，「公告本公司董事會決議召開114年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-04-11-1803-d8h6pu","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"18:03:46","subject":"公告本公司一年內累積取得同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2025-04-11","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-04-11 18:03，「公告本公司一年內累積取得同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-04-11-1753-d8h6pu","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"17:53:30","subject":"公告本公司一年內累積取得同一有價證券達實收資本額百分之二十","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-04-11 17:53，「公告本公司一年內累積取得同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-11-1527-zks4y0","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"15:27:46","subject":"公告本公司董事會決議召開114年股東常會相關事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-11 15:27，「公告本公司董事會決議召開114年股東常會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-04-11-1518-bwdfdn","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"15:18:18","subject":"本公司受邀參加第一金證券舉辦之法說會","clause":"第30款","fact_date":"2025-04-22","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-04-11 15:18，「本公司受邀參加第一金證券舉辦之法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-04-11-1508-l489j6","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-04-11","time":"15:08:53","subject":"本公司受邀參加由寬量國際主辦之「17th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-04-11 15:08，「本公司受邀參加由寬量國際主辦之「17th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-11-1455-17up2wc","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:55:35","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-11 14:55，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-04-11-1436-1uf487k","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:36:24","subject":"更正本公司114年3月資金貸與資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-04-11 14:36，「更正本公司114年3月資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-04-11-1435-14bsz5h","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:35:38","subject":"更正114年3月背書保證資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-04-11 14:35，「更正114年3月背書保證資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-11-1433-1v08jg1","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:33:44","subject":"公告本公司董事會決議辦理私募發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-11 14:33，「公告本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-04-11-1433-1ry2utj","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:33:23","subject":"本公司受邀參加寬量國際所舉辦之『17th QIC CEO Week』","clause":"第12款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-04-11 14:33，「本公司受邀參加寬量國際所舉辦之『17th QIC CEO Week』」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-11-1429-fsxigf","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:29:11","subject":"公告本公司董事會決議113年股東常會通過私募普通股案，未辦理之額度於114年股東常會後不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-11 14:29，「公告本公司董事會決議113年股東常會通過私募普通股案，未辦理之額度於114年股東常會後不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-04-11-1426-1apulf9","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-04-11","time":"14:26:30","subject":"公告本公司董事會通過稽核主管追認案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-04-11 14:26，「公告本公司董事會通過稽核主管追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2025-04-11-1134-1ihoft2","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2025-04-11","time":"11:34:42","subject":"本公司董事會決議召開114年股東常會事宜(新增議案)","clause":"第32款","fact_date":"2025-04-11","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2025-04-11 11:34，「本公司董事會決議召開114年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-04-11-0635-qtrpwo","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-04-11","time":"06:35:29","subject":"公告本公司接獲臨床合作夥伴澳洲彼得麥克林癌症中心(PMCC)來信通知由其發起運用本公司新藥Pidnarulex(CX-5461)與輝瑞PARP抑制劑合併用藥之人體臨床計畫終止。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-04-11 06:35，「公告本公司接獲臨床合作夥伴澳洲彼得麥克林癌症中心(PMCC)來信通知由其發起運用本公司新藥Pidnarulex(CX-5」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}